Physician profile
Sumit Jain
NPI 1437507316
$4,295.74
in general payments reported to CMS, 2019-2025
21 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $453 · 2021: $677 · 2022: $2,534 · 2023: $128 · 2024: $111 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,940.09 | 2021-2022 | |
| Boston Scientific Corporation | $247.45 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $219.91 | 2020-2024 | Senza |
| Stryker Corporation | $178.80 | 2025 | Mild Device Kit, Spinejack |
| Stimwave Technologies Incorporated | $94.32 | 2020 | |
| Orthofix Medical, INC. | $90.64 | 2025 | Physio-Stim |
| Bioventus LLC | $77.10 | 2025 | Xcell |
| Spr Therapeutics, INC | $71.08 | 2020 | |
| Medtronic USA, INC. | $67.15 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.78 | 2022-2023 | Relistor |
| Nalu Medical, INC. | $42.53 | 2024-2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $41.85 | 2024-2025 | |
| Almatica Pharma LLC | $35.81 | 2023 | Gralise |
| Abbott Laboratories | $26.15 | 2023 | Proclaim |
| Vertos Medical, INC. | $22.50 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $19.58 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.25 | 2023 | Xtampza |
| Amneal Pharmaceuticals LLC | $16.63 | 2022 | |
| Biodelivery Sciences International, INC. | $15.88 | 2021 | |
| Supernus Pharmaceuticals, INC. | $11.73 | 2021 | |
| Foundation Fusion Solutions, LLC | $10.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.